Press release
-
Press Release
Cision PR Newswire27 April 2026BioMarin to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, May 4, 2026, at 4:30pm ET
SAN RAFAEL, Calif., April 27, 2026 /PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and…
Read More » -
Cision PR Newswire27 April 2026
Invitation to presentation of the interim report January-March 2026 for Truecaller AB (publ)
STOCKHOLM, April 27, 2026 /PRNewswire/ — Truecaller, the leading global platform for safe and trusted communication is publishing its interim…
Read More » -
Cision PR Newswire27 April 2026
HUYA Inc. Files 2025 Annual Report on Form 20-F
GUANGZHOU, China, April 27, 2026 /PRNewswire/ — HUYA Inc. (“Huya” or the “Company”) (NYSE: HUYA), a leading game-related entertainment and…
Read More » -
Press Release
Cision PR Newswire27 April 2026Statement from United Airlines CEO Scott Kirby
CHICAGO, April 27, 2026 /PRNewswire/ — Over the last two weeks, there’s been a lot of commentary about a potential…
Read More » -
Press Release
Cision PR Newswire27 April 2026Armata Pharmaceuticals Announces Appointment of Biopharmaceutical Commercial Executive Daniel B. Gilmer, Ph.D. to its Board of Directors
LOS ANGELES, April 27, 2026 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a late clinical-stage…
Read More » -
Press Release
Cision PR Newswire27 April 2026Keeper Security Introduces Verify Mode and New Browser Controls to Prevent Phishing and Credential Misuse
New feature validates credential use at the point of entry, helping enterprises stop phishing attacks before credentials are exposed CHICAGO,…
Read More » -
Press Release
Cision PR Newswire27 April 2026Stop Guessing What Gen Next is Watching: Portrait TV Unveils Culture-First Streaming Slate Powered by AI Audience Intelligence
Launching this May, Portrait TV debuts 3,000+ hours of culture-driving, creator-led programming—including TheShop and On The Radar. MIAMI, April 27,…
Read More » -
Press Release
Cision PR Newswire27 April 2026Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera
Ajax’s lead program, AJ1-11095, is a first-in-class Type II JAK2 inhibitor currently in Phase 1 clinical development, with first proof-of-concept…
Read More » -
Press Release
Cision PR Newswire27 April 2026ebike Market worth $74.98 billion by 2035| MarketsandMarkets™
DELRAY BEACH, Fla., April 27, 2026 /PRNewswire/ — According to MarketsandMarkets™, the global ebike market is projected to grow from USD 46.39…
Read More » -
Press Release
Cision PR Newswire27 April 2026CONCEPT MEDICAL ANNOUNCES PRELIMINARY 3-YEAR SIRONA DATA AT CHARING CROSS SYMPOSIUM 2026
LONDON, April 27, 2026 /PRNewswire/ — Concept Medical Inc., today announced the presentation of preliminary 3-year follow-up data from the…
Read More »